PT Kalbe Farma Tbk (KLBF) Stock Statistics & Valuation Metrics
Total Valuation
PT Kalbe Farma Tbk has a market cap or net worth of IDR 35.34T. The enterprise value is IDR 29.19T.
- Market Cap
- IDR 35.34T
- Enterprise Value
- IDR 29.19T
Share Statistics
PT Kalbe Farma Tbk has 46,813,390,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 46,813,390,000
- Owned by Insiders
- ―
- Owned by Institutions
- 2.81%
Financial Efficiency
PT Kalbe Farma Tbk’s return on equity (ROE) is 0.16 and return on invested capital (ROIC) is 13.97%.
- Return on Equity (ROE)
- 0.16
- Return on Assets (ROA)
- 0.12
- Return on Invested Capital (ROIC)
- 13.97%
- Return on Capital Employed (ROCE)
- 0.18
- Revenue Per Employee
- 2.76B
- Profits Per Employee
- 286.19M
- Employee Count
- 12,806
- Asset Turnover
- 1.15
- Inventory Turnover
- 3.04
Valuation Ratios
The current PE Ratio of PT Kalbe Farma Tbk is 9.07. PT Kalbe Farma Tbk’s PEG ratio is 1.07.
- PE Ratio
- 9.07
- PS Ratio
- 0.89
- PB Ratio
- 1.36
- Price to FCF
- 11.54
- Price to Operating Cash Flow
- 8.93
- PEG Ratio
- 1.07
Income Statement
In the last 12 months, PT Kalbe Farma Tbk had revenue of 35.32T and earned 3.66T in profits. Earnings per share was 80.51.
- Revenue
- 35.32T
- Gross Profit
- 14.06T
- Operating Income
- 4.55T
- Pretax Income
- 4.78T
- Net Income
- 3.66T
- EBITDA
- 5.62T
- Earnings Per Share (EPS)
- 80.51
Cash Flow
In the last 12 months, operating cash flow was 3.82T and capital expenditures -866.91B, giving a free cash flow of 2.96T billion.
- Operating Cash Flow
- 3.82T
- Free Cash Flow
- 2.96T
- Free Cash Flow per Share
- 65.39
Dividends & Yields
PT Kalbe Farma Tbk pays an annual dividend of ―, resulting in a dividend yield of 2.65%
- Dividend Per Share
- ―
- Dividend Yield
- 2.65%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 8.66%
- Earnings Yield
- 11.05%
Stock Price Statistics
- Beta
- 0.59
- 52-Week Price Change
- -39.60%
- 50-Day Moving Average
- 744.30
- 200-Day Moving Average
- 829.73
- Relative Strength Index (RSI)
- 54.99
- Average Volume (3m)
- 64.88M
Important Dates
PT Kalbe Farma Tbk upcoming earnings date is Apr 01, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 30, 2026
- Next Earnings Date
- Apr 01, 2027
- Ex-Dividend Date
- ―
Financial Position
PT Kalbe Farma Tbk as a current ratio of 3.47, with Debt / Equity ratio of 1.28%
- Current Ratio
- 3.47
- Quick Ratio
- 2.16
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- -0.72
- Interest Coverage Ratio
- 128.95
Taxes
In the past 12 months, PT Kalbe Farma Tbk has paid 1.03T in taxes.
- Income Tax
- 1.03T
- Effective Tax Rate
- 0.22
Enterprise Valuation
PT Kalbe Farma Tbk EV to EBITDA ratio is 5.25, with an EV/FCF ratio of 9.81.
- EV to Sales
- 0.76
- EV to EBITDA
- 5.25
- EV to Free Cash Flow
- 9.81
- EV to Operating Cash Flow
- 7.58
Balance Sheet
PT Kalbe Farma Tbk has IDR 5.58T in cash and marketable securities with IDR 295.10B in debt, giving a net cash position of IDR 5.28T billion.
- Cash & Marketable Securities
- IDR 5.58T
- Total Debt
- IDR 295.10B
- Net Cash
- IDR 5.28T
- Net Cash Per Share
- IDR 112.88
- Tangible Book Value Per Share
- IDR 541.59
Margins
Gross margin is 37.18%, with operating margin of 12.25%, and net profit margin of 9.84%.
- Gross Margin
- 37.18%
- Operating Margin
- 12.25%
- Pretax Margin
- 12.91%
- Net Profit Margin
- 9.84%
- EBITDA Margin
- 14.42%
- EBIT Margin
- 12.32%
Analyst Forecast
The average price target for PT Kalbe Farma Tbk is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 11.44%
- EPS Growth Forecast
- 8.79%
